World Health Day: Hermes' Crockford's top six health stocks

Which medical companies have made the cut?

Jayna Rana
clock • 1 min read

As we celebrated World Health Day this past weekend (7 April), Hermes' Tim Crockford, manager of the $210m Hermes Impact Opportunities fund, highlights his favourite healthcare stocks.

With World Health Day taking place this past Sunday, Hermes' Tim Crockford, manager of the $210m Hermes Impact Opportunities fund, highlights his favourite healthcare stocks. The manager said: "Even though worldwide life expectancy is on the rise, we are far from an all-clear diagnosis for global health and wellbeing. Access to quality healthcare is unequal within and among countries, and national health systems are struggling with rising costs. "World Health Day plays a vital role in highlighting the urgent need for communities, policy makers and investors to unite and help make heal...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot